• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Heather Jacene, MD


  • Pyo J, Won Kim K, Jacene HA, Sakellis CG, Brown JR, Van den Abbeele AD.End-therapy positron emission tomography for treatment response assessment in follicular lymphoma: a systematic review and meta-analysis.Clin Cancer Res. 2013 Dec 1;19(23):6566-77.
  • Yeh ED, Jacene HA, Bellon JR, Nakhlis F, Birdwell RL, Georgian-Smith D, Giess CS, Hirshfield-Bartek J, Overmoyer B, Van den Abbeele AD.What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach.Radiographics.;33(7):2003-17.
  • Hawryluk EB, O'Regan KN, Sheehy N, Guo Y, Dorosario A, Sakellis CG, Jacene HA, Wang LC.Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: A study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women's Cancer Center.J Am Acad Dermatol. 2012 Nov 2.
  • Halasz LM, Jacene HA, Catalano PJ, Van den Abbeele AD, Lacasce A, Mauch PM, Ng AK.Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e647-54.
  • Messersmith WA, Jimeno A, Jacene H, Zhao M, Kulesza P, Laheru DA, Kahn Y, Spira A, Dancey J, Iacobuzio-Donahue C, Donehower RC, Carducci M, Rudek MA, Hidalgo M.Phase I trial of oxaliplatin, infusional 5-fluorouracil, and leucovorin (FOLFOX4) with erlotinib and bevacizumab in colorectal cancer.Clin Colorectal Cancer. 2010 Dec;9(5):297-304.
  • Goudarzi B, Jacene HA, Wahl RL.Measuring the "unmeasurable": assessment of bone marrow response to therapy using FDG-PET in patients with lymphoma.Acad Radiol. 2010 Sep;17(9):1175-85.
  • Lyford-Pike S, Ha PK, Jacene HA, Saunders JR, Tufano RP.Limitations of PET/CT in determining need for neck dissection after primary chemoradiation for advanced head and neck squamous cell carcinoma.Orl; Journal For Oto Rhino Laryngology And Its Related Specialties. 2009;71(5):251-6.
  • Jacene HA, Leboulleux S, Baba S, Chatzifotiadis D, Goudarzi B, Teytelbaum O, Horton KM, Kamel I, Macura KJ, Tsai HL, Kowalski J, Wahl RL.Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy.J Nucl Med. 2009 Nov;50(11):1760-9.
  • Wahl RL, Jacene H, Kasamon Y, Lodge MA.From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.J Nucl Med. 2009 May;50 Suppl 1:122S-50S. Review.